Dr. C. Vivek Lal, M.D. is a physician scientist, innovator and entrepreneur. He is the Clinical Director of Innovation at The Marnix Heersink Institute of Biomedical Innovation, Professor and the Director of Pulmonary Microbiome Lab at University of Alabama at Birmingham (UAB).
Dr. Lal is the Founder and CEO of ResBiotic Nutrition, Inc., a company that makes science backed wellness supplements. He is also the founder of Alveolus Bio, Inc., a platform biotech company which does FDA approved pulmonary drug development & Urgent Care for Children, a Southeast US based urgent care chain headquartered in AL. After medical school and residency training, Dr. Lal completed his clinical fellowship and research fellowship at University of Texas at Southwestern, Dallas, TX, followed by an executive program in Drug and Device Development from Massachusetts Institute of Technology (MIT).
Dr. Lal’s Microbiome Lab has been funded by NIH-NHLBI and AHA to evaluate the role of the microbiome in the development of diseases. Dr. Lal has published over 100 peer reviewed research manuscripts or abstracts and has several patents under his name as an inventor. He has won several national and international awards in the field of human biology research.
